Regulator plans to cap prices of similar drugs of same pharma company

In a bid to reduce the prices of these essential medicines, the National Pharmaceutical Pricing Authority (NPPA) has devised a new formula wherein it will consider the lowest-priced brand for price fixation of multiple brands of the same company, people aware of the development said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/1kTva4R
via IFTTT